Opus Genetics, Inc.
Opus Genetics, Inc.（IRD）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · IRD · 截至 2026年6月8日
活动摘要
买入笔数
2
P-Purchase only
卖出笔数
12
近12个月
买卖比
0.17
Buy/Sell (by trades)
整体情绪
Opus Genetics, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
IRD 季度内部人买卖趋势
IRD 内幕交易卖出 · IRD 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · IRD CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
IRD 高管卖出股份 · IRD 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 18, 2026 | Foundation Fighting Blindness Retinal Degeneration Fund Director | Sale | 1,700,000 | $7.39M⚡ | Form 4 |
| Apr 23, 2026 | YERXA BENJAMIN R President · Director | Sale | 7,470 | $39K | Form 4 |
| Apr 23, 2026 | SCHACHLE JOSEPH K COO | Sale | 4,697 | $25K | Form 4 |
| Apr 23, 2026 | Zaremba Rabourn Amy Head of Fin. Quality Assurance | Sale | 1,641 | $9K | Form 4 |
| Apr 23, 2026 | Magrath George CEO · Director | Sale | 9,511 | $50K | Form 4 |
| Apr 23, 2026 | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | Sale | 7,542 | $39K | Form 4 |
| Apr 23, 2026 | Gagnon Robert E. CFO | Sale | 7,842 | $41K | Form 4 |
| Apr 20, 2026 | Rodgers Richard J Director | Award | 24,367 | — | Form 4 |
| Apr 20, 2026 | MANUSO JAMES S J Director | Award | 24,367 | — | Form 4 |
| Apr 20, 2026 | Graves Adrienne L Director | Award | 24,367 | — | Form 4 |
| Apr 20, 2026 | Gallagher Cam Director | Award | 24,367 | — | Form 4 |
| Apr 20, 2026 | Benton Susan Director | Award | 24,367 | — | Form 4 |
| Apr 20, 2026 | Bennett Jean Director | Award | 24,367 | — | Form 4 |
| Apr 20, 2026 | Ainsworth Sean Director | Award | 24,367 | — | Form 4 |
| Mar 16, 2026 | SCHACHLE JOSEPH K COO | Sale | 3,719 | $20K | Form 4 |
| Mar 16, 2026 | Zaremba Rabourn Amy Head of Fin. Quality Assurance | Sale | 2,816 | $15K | Form 4 |
| Mar 16, 2026 | Magrath George CEO · Director | Sale | 24,438 | $127K | Form 4 |
| Mar 16, 2026 | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | Sale | 3,719 | $19K | Form 4 |
| Feb 12, 2026 | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | Other | 5,313 | $18K | Form 4 |
| Jan 22, 2026 | YERXA BENJAMIN R President · Director | Award | 400,000 | — | Form 4 |
| Jan 22, 2026 | SCHACHLE JOSEPH K COO | Award | 250,000 | — | Form 4 |
| Jan 22, 2026 | Zaremba Rabourn Amy Head of Fin. Quality Assurance | Award | 86,500 | — | Form 4 |
| Jan 22, 2026 | Magrath George CEO · Director | Award | 483,639 | — | Form 4 |
| Jan 22, 2026 | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | Award | 400,000 | — | Form 4 |
| Jan 22, 2026 | Gagnon Robert E. CFO | Award | 400,000 | — | Form 4 |
Foundation Fighting Blindness Retinal Degeneration Fund
Director
日期
May 18
股数
1,700,000
均价
$4.35
总金额
$7.39M ⚡
Zaremba Rabourn Amy
Head of Fin. Quality Assurance
日期
Apr 23
股数
1,641
均价
$5.20
总金额
$9K
Jayagopal Ashwath
Chief Scientific & Dev. Ofc.
日期
Apr 23
股数
7,542
均价
$5.19
总金额
$39K
Zaremba Rabourn Amy
Head of Fin. Quality Assurance
日期
Mar 16
股数
2,816
均价
$5.25
总金额
$15K
Jayagopal Ashwath
Chief Scientific & Dev. Ofc.
日期
Mar 16
股数
3,719
均价
$5.12
总金额
$19K
Jayagopal Ashwath
Chief Scientific & Dev. Ofc.
日期
Feb 12
股数
5,313
均价
$3.39
总金额
$18K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 IRD 内幕交易
IRD 内幕交易
Opus Genetics, Inc.（IRD）内幕交易数据来源于公司内部人（包括Gallagher Cam (Director), Zaremba Rabourn Amy (Head of Fin. Quality Assurance), Magrath George (CEO · Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。IRD内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Opus Genetics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
IRD 内幕交易 · 5个问题Opus Genetics, Inc.（IRD）的内部人包括高管和董事，如Gallagher Cam (Director), Zaremba Rabourn Amy (Head of Fin. Quality Assurance), Magrath George (CEO · Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026